[HTML][HTML] COPD–do the right thing
H Sandelowsky, UM Weinreich, BB Aarli, J Sundh… - BMC family …, 2021 - Springer
A gap exists between guidelines and real-world clinical practice for the management and
treatment of chronic obstructive pulmonary disease (COPD). Although this has narrowed in the …
treatment of chronic obstructive pulmonary disease (COPD). Although this has narrowed in the …
[HTML][HTML] A safe and effective micro-choice based rehabilitation for patients with long COVID: results from a quasi-experimental study
…, B Espehaug, KL Njøten, E Søfteland, BB Aarli… - Scientific Reports, 2023 - nature.com
… Bernt Bøgvald Aarli has received Grants, consulting fees or honoraria from Boehringer
Ingelheim, GlaxoSmithKline, Astra Zeneca, Novartis and Sanofi-Aventis. Bente Frisk, Marte …
Ingelheim, GlaxoSmithKline, Astra Zeneca, Novartis and Sanofi-Aventis. Bente Frisk, Marte …
Variability of within-breath reactance in COPD patients and its association with dyspnoea
BB Aarli, PMA Calverley, RL Jensen… - European respiratory …, 2015 - Eur Respiratory Soc
The forced oscillation technique can identify expiratory flow limitation (EFL) when a large
difference in inspiratory and expiratory reactance (ΔX rs ) occurs. However, flow limitation can …
difference in inspiratory and expiratory reactance (ΔX rs ) occurs. However, flow limitation can …
Adult severe asthma registries: a global and growing inventory
…, JFM van Boven, BB Aarli… - Pragmatic and …, 2023 - Taylor & Francis
… Bernt Bøgvald Aarli reports grants from Boehringer Ingelheim during the conduct of the study
and personal fees from Boehringer Ingelheim, AstraZeneca, GSK, Sanofi-Aventis Norway, …
and personal fees from Boehringer Ingelheim, AstraZeneca, GSK, Sanofi-Aventis Norway, …
[HTML][HTML] Prevalence and management of severe asthma in the Nordic countries: findings from the NORDSTAR cohort
…, H Kankaanranta, C Ulrik, BB Aarli… - ERJ open …, 2023 - Eur Respiratory Soc
… BB Aarli reports consulting fees from GSK and AstraZeneca, lecture fees from GSK,
AstraZeneca, Sanofi-Aventis Norge, Novartis and Boehringer Ingelheim, and participation in …
AstraZeneca, Sanofi-Aventis Norge, Novartis and Boehringer Ingelheim, and participation in …
[HTML][HTML] Severe asthma trajectories in adults: findings from the NORDSTAR cohort
…, H Kankaanranta, C Ulrik, BB Aarli… - European …, 2023 - Eur Respiratory Soc
… BB Aarli reports grants from Novartis, consulting fees from AstraZeneca, lecture fees from
GSK, AstraZeneca, Sanofi-Aventis, Novartis and Boehringer Ingelheim, and participation in …
GSK, AstraZeneca, Sanofi-Aventis, Novartis and Boehringer Ingelheim, and participation in …
[HTML][HTML] A prospective study of pulmonary outcomes and chest computed tomography in the first year after COVID-19
…, TM Aaløkken, E Brønstad, BB Aarli… - ERJ open …, 2023 - Eur Respiratory Soc
… Conflict of interest: BB Aarli reports personal fees for lectures and advisory board work
from AstraZeneca, personal fees for lectures from GlaxoSmithKline, Novartis, Boehringer …
from AstraZeneca, personal fees for lectures from GlaxoSmithKline, Novartis, Boehringer …
The association of tidal EFL with exercise performance, exacerbations, and death in COPD
BB Aarli, PMA Calverley, RL Jensen… - … journal of chronic …, 2017 - Taylor & Francis
Background Tidal expiratory flow limitation (EFL T ) is frequently found in patients with
COPD and can be detected by forced oscillations when within-breath reactance of a single-breath …
COPD and can be detected by forced oscillations when within-breath reactance of a single-breath …
Relationship between exercise capacity and fatigue, dyspnea, and lung function in non‐hospitalized patients with long COVID
…, G Kvale, E Søfteland, BB Aarli… - Physiological …, 2023 - Wiley Online Library
… Søfteland, Birgitte Espehaug, Bernt Bøgvald Aarli, and Liv Heide Magnussen made substantial
… Bernt Bøgvald Aarli has received grants, consulting fees or honoraria from Boehringer …
… Bernt Bøgvald Aarli has received grants, consulting fees or honoraria from Boehringer …
[HTML][HTML] Evaluation of novel concentrated interdisciplinary group rehabilitation for patients with chronic illnesses: Protocol for a nonrandomized clinical intervention …
…, A Wilhelmsen-Langeland, BB Aarli… - JMIR Research …, 2021 - researchprotocols.org
Background: An aging population with a growing burden of chronic complex illnesses will
seriously challenge the public health care system. Consequently, novel and efficacious …
seriously challenge the public health care system. Consequently, novel and efficacious …